HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Cohort
Combination valsartan and dapagliflozin improves blood pressure and glucose in Type 2 Diabetes and hypertension.
Two Common Heart and Kidney Drugs Work Better Together Than Alone
This retrospective cohort study of 245 patients with coexisting Type 2 Diabetes Mellitus and hypertension found that combination therapy wit…
For patients with diabetes and high blood pressure, combining two common medications may offer stronger protection for the heart and kidneys…
Frontiers
Apr 24, 2026
Cardiology
Meta-analysis
Sacubitril/valsartan shows greater LVMI regression than some antihypertensives in hypertension with remodeling
New Drug Shrinks Heart Muscle Better Than Old Options
A network meta-analysis of 851 patients with essential hypertension and cardiovascular remodeling found sacubitril/valsartan achieved greate…
A new analysis shows one specific medicine shrinks thickened heart muscle better than older blood pressure treatments, offering hope for rev…
Frontiers
Apr 14, 2026